KELLY DISTELRATH: Open Payments
NPI 1477151280 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,584 in 135 payments from 30 companies in 2025. Trend: 2023 $2,246 · 2024 $2,646 · 2025 $2,584
Food & beverage: $2,564Education: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $449 |
| Novo Nordisk Inc | 20 | $375 |
| AstraZeneca Pharmaceuticals LP | 11 | $280 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $244 |
| PFIZER INC. | 8 | $145 |
| Lilly USA, LLC | 5 | $94 |
| GlaxoSmithKline, LLC. | 5 | $93 |
| Amgen Inc. | 4 | $71 |
| SHIELD THERAPEUTICS INC | 3 | $67 |
| Kowa Pharmaceuticals America, Inc. | 3 | $59 |
Products named: CAPLYTA, QULIPTA, BREZTRI, UBRELVY, Wegovy, VRAYLAR, AIRSUPRA, Rybelsus.
Industry payments across PA — which companies pay providers there.
